These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21784354)

  • 21. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patients.
    Helisalmi S; Hall A; Meriläinen EH; Väisänen V; Koivisto AM; Herukka SK; Laitinen M; Soininen H; Hiltunen M
    Neurodegener Dis; 2014; 14(4):204-8. PubMed ID: 25500937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Transl Psychiatry; 2014 Sep; 4(9):e449. PubMed ID: 25247594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region.
    Jun G; Vardarajan BN; Buros J; Yu CE; Hawk MV; Dombroski BA; Crane PK; Larson EB; ; Mayeux R; Haines JL; Lunetta KL; Pericak-Vance MA; Schellenberg GD; Farrer LA
    Arch Neurol; 2012 Oct; 69(10):1270-9. PubMed ID: 22869155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
    Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
    J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
    Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B
    Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.
    Roses AD
    Arch Neurol; 2010 May; 67(5):536-41. PubMed ID: 20457951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline.
    Yu L; Lutz MW; Farfel JM; Wilson RS; Burns DK; Saunders AM; De Jager PL; Barnes LL; Schneider JA; Bennett DA
    Alzheimers Dement; 2017 Dec; 13(12):1380-1388. PubMed ID: 28624335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.
    Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY
    Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly.
    Pomara N; Bruno D; Sidtis JJ; Lutz MW; Greenblatt DJ; Saunders AM; Roses AD
    J Clin Psychopharmacol; 2011 Aug; 31(4):544-6. PubMed ID: 21720235
    [No Abstract]   [Full Text] [Related]  

  • 33. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases.
    Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease.
    Zeitlow K; Charlambous L; Ng I; Gagrani S; Mihovilovic M; Luo S; Rock DL; Saunders A; Roses AD; Gottschalk WK
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2973-2986. PubMed ID: 28768149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease.
    Multhammer M; Michels A; Zintl M; Mendoza MC; Klünemann HH
    Acta Neurol Belg; 2014 Mar; 114(1):25-31. PubMed ID: 23794363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
    Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
    Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
    J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of
    Nishimura A; Nonomura H; Tanaka S; Yoshida M; Maruyama Y; Aritomi Y; Saunders AM; Burns DK; Lutz MW; Runyan G; Lai E; Budur K; Roses AD
    Alzheimers Dement (N Y); 2017 Nov; 3(4):524-530. PubMed ID: 29124110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Willette AA; Webb JL; Lutz MW; Bendlin BB; Wennberg AM; Oh JM; Roses A; Koscik RL; Hermann BP; Dowling NM; Asthana S; Johnson SC;
    Alzheimers Dement; 2017 Nov; 13(11):1217-1225. PubMed ID: 28549947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.